Veracyte | VCYT - SCHULD

Aktienkurs
41.71
Täglich Wechseln
0.21 0.51%
Monatlich
24.69%
Jährlich
44.78%
Q2 Prognose
37.71




SCHULD Veränderung Datum
Agenus USD 35.54M 2.34M 2025-03
Agilent USD 3.35B 55M 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 312.77M 53.52M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Heron Therapeutics USD 149.65M 157K 2024-09
Illumina USD 2.55B 23M 2025-12
Intrexon USD 0 13.82M 2024-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Laboratory Of America USD 6.53B 3.9M 2025-12
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Siemens EUR 56.46B 450M 2025-12
Sonic Healthcare AUD 4.8B 282.9M 2024-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Veracyte USD 39.65M 799K 2025-12
Waters USD 1.49B 4.92M 2025-12